Kyung Nam Pharm Co Ltd Capital Reinvestment Ratio
Kyung Nam Pharm Co Ltd capital reinvestment ratio. Kyung Nam Pharm Co Ltd (053950) has a Capital Reinvestment Ratio of 47.04x as of June 2026, meaning it reinvests 47% of its operating cash flow (₩81.44 Million) in capital expenditures (₩3.83 Billion). Check 053950 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kyung Nam Pharm Co Ltd (2007–2024)
Capital reinvestment ratio of Kyung Nam Pharm Co Ltd from 2007 to 2024. This chart tracks Kyung Nam Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore Kyung Nam Pharm Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Kyung Nam Pharm Co Ltd Capital Reinvestment Ratio by Year (2007–2024)
Kyung Nam Pharm Co Ltd capital reinvestment ratio by year from 2007 to 2024. For the full cash flow conversion analysis, see 053950 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.91x | ₩1.84 Billion | ₩1.67 Billion | ▼ -85.0% |
| 2023 | 6.02x | ₩693.30 Million | ₩4.18 Billion | ▼ -85.2% |
| 2022 | 40.77x | ₩71.58 Million | ₩2.92 Billion | ▲ +133.9% |
| 2020 | 17.43x | ₩2.62 Billion | ₩45.58 Billion | ▲ +2749.8% |
| 2017 | 0.61x | ₩1.72 Billion | ₩1.05 Billion | ▲ +169.5% |
| 2016 | 0.23x | ₩4.89 Billion | ₩1.11 Billion | ▼ -99.0% |
| 2010 | 22.56x | ₩482.65 Million | ₩10.89 Billion | ▼ -15.9% |
| 2007 | 26.83x | ₩148.79 Million | ₩3.99 Billion | — |